相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuroblastoma mRNAs Predict Outcome in Children With Stage 4 Neuroblastoma: AEuropean HR-NBL1/SIOPEN Study
Virginie F. Viprey et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Role of Cripto-1 during Epithelial-to-Mesenchymal Transition in Development and Cancer
Maria C. Rangel et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Prognostic Significance of Promoter DNA Methylation in Patients with Childhood Neuroblastoma
Diana T. Lau et al.
CLINICAL CANCER RESEARCH (2012)
DNA Hypomethylation Affects Cancer-Related Biological Functions and Genes Relevant in Neuroblastoma Pathogenesis
Gemma Mayol et al.
PLOS ONE (2012)
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
Anneleen Decock et al.
GENOME BIOLOGY (2012)
miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples
Katleen De Preter et al.
CLINICAL CANCER RESEARCH (2011)
Differential expression in RNA-seq: A matter of depth
Sonia Tarazona et al.
GENOME RESEARCH (2011)
Hypermethylation of Apoptotic Genes as independent Prognostic Factor in Neuroblastoma Disease
Elena Grau et al.
MOLECULAR CARCINOGENESIS (2011)
Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia
Meena Kanduri et al.
BLOOD (2010)
Targeting the embryonic gene Cripto-1 in cancer and beyond
Caterina Bianco et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
Johannes H. Schulte et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients
E. Grau et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Defining Hypo-Methylated Regions of Stem Cell-Specific Promoters in Human iPS Cells Derived from Extra-Embryonic Amnions and Lung Fibroblasts
Koichiro Nishino et al.
PLOS ONE (2010)
Cripto-1 Is a Cell Surface Marker for a Tumorigenic, Undifferentiated Subpopulation in Human Embryonal Carcinoma Cells
Kazuhide Watanabe et al.
STEM CELLS (2010)
Aberrant methylation of candidate tumor suppressor genes in neuroblastoma
Jasmien Hoebeeck et al.
CANCER LETTERS (2009)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
Joelel Vermeulen et al.
LANCET ONCOLOGY (2009)
Genome-wide DNA methylation profiling using Infinium (R) assay
Marina Bibikova et al.
EPIGENOMICS (2009)
Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis
Masanobu Abe et al.
ONCOLOGY (2008)
Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors
Mariana Bohns Michalowski et al.
PEDIATRIC BLOOD & CANCER (2008)
Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome
Qiwei Yang et al.
CLINICAL CANCER RESEARCH (2007)
Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors:: a study of 182 cases from the Spanish Neuroblastoma Registry
Octavio Burgues et al.
VIRCHOWS ARCHIV (2006)
Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma
R Spitz et al.
CLINICAL CANCER RESEARCH (2006)
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group
WB London et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma
M Alaminos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Aberrant methylation of multiple genes in neuroblastic tumours:: relationship with MYCN amplification and allelic status at 1p
P Gonzalez-Gomez et al.
EUROPEAN JOURNAL OF CANCER (2003)
Quality assessment of genetic markers used for therapy stratification
IM Ambros et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
MYCN gain and MYCN amplification in a stage 4S neuroblastoma
R Noguera et al.
CANCER GENETICS AND CYTOGENETICS (2003)
CpG island methylation status and mutation analysis of the RBI gene essential promoter region and protein-binding pocket domain in nervous system tumours
P Gonzalez-Gomez et al.
BRITISH JOURNAL OF CANCER (2003)
Promoter hypermethylation of the RB1 gene in glioblastomas
M Nakamura et al.
LABORATORY INVESTIGATION (2001)
分享论文
